3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
55
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
Myelodysplastic Syndromes
40
Multiple Myeloma
34
Lymphoma
32
Leukemia
28
Lymphoma, Non-Hodgkin
27
Leukemia, Lymphocytic, Chronic, B-Cell
24
Hodgkin Disease
21
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
20
Hematologic Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
16
Primary Myelofibrosis
11
Neoplasms, Plasma Cell
10
Leukemia, Myelomonocytic, Chronic
10
Lymphoma, Follicular
9
Graft vs Host Disease
9
Myeloproliferative Disorders
8
Neuroblastoma
7
Leukemia, Myelomonocytic, Juvenile
7
Lymphoma, Mantle-Cell
6
Breast Neoplasms
6
Recurrence
5
Neoplasms
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Biphenotypic, Acute
5
Wilms Tumor
4
Rhabdoid Tumor
4
Polycythemia Vera
4
Lymphoma, T-Cell
4
Interventions
ruxolitinib
1
posaconazole
1
Stem Cell Transplantation
1
Low-Level Light Therapy
1
Hydroxyurea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Bone Marrow Neoplasms
×
Stem Cell Transplantation
×
Clear all
NCT04217356
2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
90 enrolled